Day 2 :
Keynote Forum
Tanya Lochner
Brain Harmonics, South Africa
Keynote: Neurofeedback and epilepsy – A critical review of using neurofeedback as an alternative treatment for epilepsy
Time : 09:30-10:30
Biography:
Abstract:
We will do a critical review of using operant conditioning of the sensorimotor rhythm (SMR) as a clinical utility and alternative treatment for epilepsy. Issues taken into consideration will include physiology, learning principles, and methodology while focusing on the treatment of epilepsy with sensorimotor rhythm training, probably the best established clinical application of EEG-operant conditioning. The skilled practice of neurofeedback requires a solid understanding of operant learning principles and mechanisms, the neurophysiology underlying EEG oscillation, as well as an in-depth comprehension of how the various hardware/software equipment options work, that are currently available to the practitioner. It has been suggested that the best clinical practice includes the systematic mapping of quantitative multi-electrode EEG measures against a standard norm sample base before and after treatment, to guide the choice of treatment and record progress towards EEG standardization. We conclude that research literature, as well as practical case studies, justifies the idea that neurofeedback treatment of epilepsy/seizure disorders may be a well-founded and viable alternative to anticonvulsant pharmacotherapy.
- Depression and Anxiety | Epilepsy and Alcohol | Epilepsy in Woman and Inborn | Drug Delivery to Epilepsy Brain | Epilepsy Surgery | Prevention of Epilepsy
Location: Cape Town, South Africa
Chair
Guillermo Nicolás Jemar
TREMA Mental Health and Neurosciences, Argentina
Session Introduction
Pani Schutte
Eskom Holdings SOC Ltd, South Africa
Title: The impact of cognitive impairment on the workplace (employer and employee) and needed collaboration between the employer and the specialists
Time : 11:00-11:30
Biography:
Pani Schutte has completed two Masters degrees in Psychology and Clinical Psychology and a DPhil in Psychology from Stellenbosch University. The topic of her study was Exposure Therapy and Brain Metabolic Changes in the Treatment of PTSD. Dr. Schutte is currently the Senior Station Psychologist at Koeberg Nuclear Power Station, Eskom Holdings SOC, South Africa. The main focus of her role is providing assurance to the National Nuclear Regulator, and thereby to the public, that no adverse event will occur at KNPS due to psychological deficiencies of nuclear operators. Dr. Schutte has a strong interest in Neuropsychological Assessments and Interventions. She has published and presented over 15 papers, both nationally and internationally
Abstract:
The burden of Brain Disorders on the society is immense and can be considered one the top global health challenges of the 21st century. This is one of the findings of a recent report, coordinated by the European Brain Council (EBC) and the European College of Neuropsychopharmacology (ECNP). The societal and workplace burden increases when the net is cast a little wider to include the broader area of Cognitive Impairment due to various etiologies. Cognitive Impairment can develop gradually as a result of a disease, or suddenly as a result of a specific injury. In either case, the individual may seem to make a full recovery but may have subtle “invisible” cognitive impairment, which may have a major negative impact on their workability and productivity. This, in turn, has a major cost effect on the employer with regards to direct costs (salary, sick leave, etc.) as well as indirect costs (burnout of and resignations by other employees taking on an extra load, decreased production, etc). How do we manage individuals with cognitive impairment? Fulfilling our ethical obligation, we as health care practitioners have to take hands with organizations, collaborating in the design and implementation of programmes and systems to work in the best interest of the individuals and the organizations. to make a full recovery, but may have subtle “invisible” cognitive impairment, which may have a major negative impact on their workability and productivity. This, in turn, has a major cost effect on the employer with regards to direct costs (salary, sick leave, etc.) as well as indirect costs (burnout of and resignations by other employees taking on an extra load, decreased production, etc). How do we manage individuals with cognitive impairment? Fulfilling our ethical obligation, we as health care practitioners have to take hands with organizations, collaborating in the design and implementation of programmes and systems to work in the best interest of the individuals and the organizations.
Nada Lagerstrom,
Valkenberg Hospital, South Africa